{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:29:28Z","timestamp":1760142568829,"version":"build-2065373602"},"reference-count":27,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.biopha.2011.11.006","type":"journal-article","created":{"date-parts":[[2011,12,21]],"date-time":"2011-12-21T09:45:13Z","timestamp":1324460713000},"page":"578-582","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Pretreatment prognostic factors for overall survival in primary resistant acute myeloid leukemia"],"prefix":"10.1016","volume":"66","author":[{"given":"N.","family":"Colovic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Tomin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Vidovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Suvajdzic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Jankovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Palibrk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Djunic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Djurasinovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Virijevic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2011.11.006_bib0005","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1182\/asheducation-2009.1.396","article-title":"Optimal induction and post-remission therapy for AML in first remission","author":"Rowe","year":"2009","journal-title":"Hematol Am Soc Hematol Educ Prog"},{"key":"10.1016\/j.biopha.2011.11.006_bib0010","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.bbmt.2010.02.004","article-title":"Prognostic factors and quality of life analysis in 160 patients aged>or=to 60 years with hematologic neoplasias treated with allogeneic hematopoietic cell transplantation","volume":"16","author":"Deschler","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.biopha.2011.11.006_bib0015","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/MOH.0b013e3282f463d2","article-title":"Novel strategies for relapsed and refractory acute myeloid leukemia","volume":"15","author":"Mato","year":"2008","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.biopha.2011.11.006_bib0020","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/ajh.20526","article-title":"Expression of MAC-1 (CD11b) in acute myeloid leukemia (AML) is associated with unfavorable prognosis","volume":"81","author":"Graf","year":"2006","journal-title":"Am J Hematol"},{"key":"10.1016\/j.biopha.2011.11.006_bib0025","first-page":"71","article-title":"The immunophenotype of acute myeloid leukemia: is there a relationship with prognosis?","volume":"20","author":"Mason","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2011.11.006_bib0030","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1182\/blood.V92.7.2322","article-title":"The importance of diagnostic cytogenetics on outcome in AML: analysis of 1612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties","volume":"92","author":"Grimwade","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2011.11.006_bib0035","series-title":"Acute myelogenous leukemia","first-page":"177","article-title":"Impact of cytogenetics on clinical outcome in AML","author":"Grimwade","year":"2007"},{"key":"10.1016\/j.biopha.2011.11.006_bib0040_1","doi-asserted-by":"crossref","first-page":"620","DOI":"10.7326\/0003-4819-103-4-620","article-title":"Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group","volume":"103","author":"Bennett","year":"1985","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.biopha.2011.11.006_bib0040_2","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1002\/cncr.21723","article-title":"Results of intensive chemotherapy in 998 patients age 65 years or older with acute myeloid leukemia or high-risk myelodysplastic syndrome","volume":"106","author":"Kantarjian","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.biopha.2011.11.006_bib0045","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","first-page":"150","article-title":"Acute leukemias of ambiguous lineage","author":"Borowitz","year":"2008"},{"key":"10.1016\/j.biopha.2011.11.006_bib0050","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","article-title":"Toxicity and response criteria of the Eastern Cooperative Oncology Group","volume":"5","author":"Oken","year":"1982","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.biopha.2011.11.006_bib0055","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1182\/blood-2005-05-2004","article-title":"Hematopoetic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogenic HCT","volume":"106","author":"Sorror","year":"2005","journal-title":"Blood"},{"year":"2001","series-title":"Pathology and genetics of tumours of haematopoietic and lymphoid tissues","key":"10.1016\/j.biopha.2011.11.006_bib0060"},{"key":"10.1016\/j.biopha.2011.11.006_bib0065","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0165-4608(94)90007-8","article-title":"Rapid method for obtaining high quality chromosome banding in the study of hemopoietic neoplasia","volume":"74","author":"Novak","year":"1994","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.biopha.2011.11.006_bib0070","unstructured":"ISCN (2009): An international system for human cytogenetic nomenclature. L.G. Shaffer, M.L. Slovak, L.J. Campbell (Eds.); S. Karger, Basel, 2009."},{"key":"10.1016\/j.biopha.2011.11.006_bib0075","doi-asserted-by":"crossref","first-page":"4075","DOI":"10.1182\/blood.V96.13.4075","article-title":"Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group\/Eastern Cooperative Oncology Group study","volume":"96","author":"Slovak","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2011.11.006_bib0080","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1200\/JCO.1990.8.5.813","article-title":"Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia","volume":"8","author":"Cheson","year":"1990","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.biopha.2011.11.006_bib0085","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1007\/s00277-003-0730-1","article-title":"Salvage by timed sequential chemotherapy in primary resistant acute myeloid leukemia: analysis of prognostic factors","volume":"82","author":"Revesz","year":"2003","journal-title":"Ann Hematol"},{"key":"10.1016\/j.biopha.2011.11.006_bib0090","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.1182\/blood-2006-04-014324","article-title":"Cytogenetics and age are major determinants of outcome in intensively treated acute myeloid leukemia patients older than 60 years: results from AMLS G trial HD98-B","volume":"108","author":"Frohling","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2011.11.006_bib0095","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1182\/blood.V98.6.1752","volume":"98","author":"Kottaridis","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2011.11.006_bib0100","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1056\/NEJMoa041974","article-title":"Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype","volume":"352","author":"Falini","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.biopha.2011.11.006_bib0105","doi-asserted-by":"crossref","first-page":"4011","DOI":"10.1182\/blood-2005-08-3167","article-title":"Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML)","volume":"107","author":"Thiede","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2011.11.006_bib0110","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s00277-007-0325-3","article-title":"Importance of early detection and follow-up of FLT3 mutations in patients with acute myeloid leukemia","volume":"86","author":"\u010colovi\u0107","year":"2007","journal-title":"Ann Hematol"},{"key":"10.1016\/j.biopha.2011.11.006_bib0115","doi-asserted-by":"crossref","first-page":"3733","DOI":"10.1182\/blood-2005-06-2248","article-title":"Nucleophosmin gene mutations are predictors of favorable prognosis in acute myelogenous leukemia with normal Karyotype","volume":"106","author":"Schnittger","year":"2005","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.biopha.2011.11.006_bib0120","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1093\/carcin\/bgn168","article-title":"MN1 affects expression of genes involved in hematopoiesis and can enhance as well as inhibit RAR\/RXR induced gene expression","volume":"29","author":"Smoor","year":"2008","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.biopha.2011.11.006_bib0125","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1046\/j.1365-2141.1998.00561.x","article-title":"Acute myeloid leukaemia expressing the leucocyte integrin CD11b: a new leukaemic syndrome with poor prognosis: result of an ECOG database analysis","volume":"100","author":"Paietta","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1016\/j.biopha.2011.11.006_bib0130","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1182\/blood-2008-05-157065","article-title":"Time from diagnosis to treatment initiation predicts survival in younger, but not older, acute myeloid leukemia","volume":"113","author":"Sekeres","year":"2009","journal-title":"Blood"}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332211001557?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332211001557?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T10:50:28Z","timestamp":1760093428000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332211001557"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":27,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S0753332211001557"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2011.11.006","relation":{},"ISSN":["0753-3322"],"issn-type":[{"type":"print","value":"0753-3322"}],"subject":[],"published":{"date-parts":[[2012,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pretreatment prognostic factors for overall survival in primary resistant acute myeloid leukemia","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2011.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}